This Pharma Stock Has An Upside Potential of 22%

Motilal Oswal Institutional Equities has placed a "buy" call on the stock of Strides Pharma with a price target of Rs 650, implying an upside potential of 22 per cent from the current market price. Superior execution leads to recovery in

from Tax Saving Investments | Tax Saving Tips & News | Income Tax India – Oneindia Money https://ift.tt/3a8wfXw
via IFTTT